Trial · NCT03364231
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Overall Response Rate (ORR) as Assessed by Revised Response Criteria for Non- Hodgkin's Lymphoma (Lugano Classification) and Consensus-Based 6th International Workshop on Waldenstrom's Macroglobulinemia (IWWM) | MZL: Umbralisib | 37.5 | 95% Confidence Interval 8.5 to 75.5 | percentage of participants | |
Overall Response Rate (ORR) as Assessed by Revised Response Criteria for Non- Hodgkin's Lymphoma (Lugano Classification) and Consensus-Based 6th International Workshop on Waldenstrom's Macroglobulinemia (IWWM) | WM: Umbralisib | 30.0 | 95% Confidence Interval 6.7 to 65.2 | percentage of participants | |
| Duration of Response (DOR) | MZL: Umbralisib | 21.2 | Full Range 3 to 33 | months | |
| Duration of Response (DOR) | WM: Umbralisib | 13 | Full Range 5 to 14 | months | |
| Complete Response (CR) Rate | MZL: Umbralisib | 12.5 | 95% Confidence Interval 0.3 to 52.7 | percentage of participants | |
| Complete Response (CR) Rate | WM: Umbralisib | 0 | 95% Confidence Interval NA to NA | percentage of participants | |
| Progression-Free Survival (PFS) | MZL: Umbralisib | 47.1 | Full Range 1.4 to 47.1 | months | |
| Progression-Free Survival (PFS) | WM: Umbralisib | 18.4 | Full Range 2.1 to 35.0 | months | |
| Time to Treatment Failure (TTF) | MZL: Umbralisib | 13.1 | 95% Confidence Interval 1.4 to NA | months | |
| Time to Treatment Failure (TTF) | WM: Umbralisib | 6.5 | 95% Confidence Interval 2.1 to 15.9 | months | |
| Number of Participants With at Least One Adverse Event (AE) | MZL: Umbralisib | 8 | Participants | ||
| Number of Participants With at Least One Adverse Event (AE) | WM: Umbralisib | 13 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03364231/results